Weighing Immunotherapy/Chemotherapy Options in NSCLC

Dr. Hossein Borghaei discusses results of the Checkmate 227 trial and its impact on treatment decision-making in NSCLC.

Source: CancerNetwork - June 20, 2018 Category: Cancer & Oncology Authors: Hossein Borghaei, DO, MS Source Type: news